Konstantina Skourti-Stathaki, PhD (she/her/hers)

N-Lorem Foundation, California, United States

Dr. Konstantina Skourti-Stathaki is the Director of ASO Discovery and Design at n-Lorem Foundation, where she leads and oversees Discovery and Core Research programs. Prior to n-Lorem, Konstantina led the RNA Biology and Technology team at MiNA Therapeutics, where she specialized and oversaw pre-clinical RNA Therapeutics drug discovery, specifically target identification and validation, oligonucleotide design and targeting, and mechanism of action studies. Prior to her industry position, Konstantina spent 15 years in academia and her expertise is on RNA biology and biochemistry, transcription and epigenetics. Konstantina did her PhD at the University of Oxford and was then awarded a prestigious Sir Henry Wellcome fellowship which she spent at the University of Edinburgh, UK and the Max Delbruck Centre for Molecular Medicine in Berlin, Germany. Konstantina holds a personal award for 'Women In Science' from L'Oreal UK&Ireland, and she has a strong track record of innovative research including numerous high impact factor peer-reviewed publications and patent filings.

Disclosure information not submitted.

Presentation(s):

• Oligonucleotide modalities in RNA Therapeutics: the critical steps of target Identification and oligonucleotide design in drug discovery

  Monday, February 5, 2024
  10:30 AM – 11:00 AM EST